Search

Your search keyword '"Marija Pfeifer"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Marija Pfeifer" Remove constraint Author: "Marija Pfeifer" Topic humans Remove constraint Topic: humans
37 results on '"Marija Pfeifer"'

Search Results

1. Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)

2. Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway

Catalog

Books, media, physical & digital resources

3. Adrenal failure and antiphospholipid syndrome

4. Vitamin D Supplementation During the COVID-19 Pandemic

5. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors

6. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes

7. MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

8. DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview

9. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma

10. Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN

11. The penetrance of MEN2 pheochromocytoma is not only determined by

12. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN

13. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome

14. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

15. Variations inPROKR2, But NotPROK2, Are Associated With Hypopituitarism and Septo-optic Dysplasia

16. The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

17. XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function

18. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome

19. Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series

20. Comparison of different methods investigating functional and morphological markers of early atherogenesis in obese women with polycystic ovary syndrome

21. Identifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging Issue

22. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

23. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

24. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

25. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study

26. Growth hormone (GH) andatherosclerosis: changes in morphology and function of major arteries during GH treatment

27. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome

28. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome

29. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity

30. Decreased lipin 1 beta expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome

31. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

32. Assessment of insulin resistance in young women with polycystic ovary syndrome

33. Molecular mechanisms of insulin resistance and associated diseases

34. Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism

35. Endothelial dysfunction in endocrine disease

36. Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults

37. Oncogene-induced senescence in pituitary adenomas and carcinomas